Blood Pressure Guide: AHA 2017 Classification and Healthy Ranges

Understanding Blood Pressure Numbers

Blood pressure is recorded as two numbers and measured in millimetres of mercury (mmHg). The systolic pressure (top number) is the pressure when your heart beats; the diastolic (bottom number) is the pressure between beats. A reading of 120/80 mmHg is the upper limit of normal for adults.

Hypertension is the single leading modifiable risk factor for cardiovascular disease worldwide. Roughly 1.28 billion adults aged 30–79 have hypertension globally, and nearly half are unaware of it (NCD-RisC, Lancet 2021, PMID 34450083). Because elevated pressure is usually silent, measurement is the only way to detect it before end-organ damage occurs.

AHA 2017 Classification for Adults

The American Heart Association updated its classification in 2017 (Whelton PK et al., PMID 29133356), lowering the hypertension threshold from 140/90 to 130/80 mmHg to align with evidence showing cardiovascular risk increases significantly above this level.

Why 130/80 Instead of 140/90 — What Changed in 2017

The threshold drop was driven largely by the SPRINT trial (Wright JT et al., NEJM 2015, PMID 26551272), which randomized 9,361 high-risk adults without diabetes to a systolic target below 120 mmHg vs below 140 mmHg. The intensive-control arm had a 25% lower rate of major cardiovascular events and a 27% lower all-cause mortality, and the trial was stopped early for benefit.

Combined with observational data showing that cardiovascular risk begins to climb above 115/75 mmHg, the ACC/AHA 2017 panel concluded that a 130/80 threshold better identifies adults who would benefit from lifestyle intervention or pharmacotherapy. Not every guideline body agreed — the European ESC/ESH still uses 140/90 for the diagnostic threshold but treats earlier in high-risk patients — so context matters. Discuss your individual target with your physician.

Pediatric Blood Pressure (AAP 2017)

In children and adolescents (ages 1–17), blood pressure norms are age-, sex-, and height-specific. The AAP 2017 guideline (Flynn JT et al., PMID 28827377) defines: Normal: <90th percentile; Elevated: 90th–94th; Stage 1 HTN: ≥95th; Stage 2 HTN: ≥99th+5 mmHg or ≥140/90.

How to Measure Blood Pressure Correctly

Home Monitoring vs Office Measurement

The ACC/AHA 2017 guideline (PMID 29133356) and the 2020 ISH global guidelines (Unger T et al., PMID 32370572) both recommend out-of-office measurement — either home BP monitoring (HBPM) or 24-hour ambulatory BP monitoring (ABPM) — to confirm a diagnosis of hypertension before starting lifelong therapy. Office readings alone overestimate or underestimate true pressure in a meaningful fraction of patients.

A practical home protocol: measure twice in the morning and twice in the evening for 7 consecutive days, discard day 1, and average the rest. Thresholds shift slightly out of office — 130/80 mmHg in clinic corresponds to roughly 130/80 mmHg on home average and 125/75 mmHg on 24-h ambulatory average (ACC/AHA 2017, PMID 29133356).

Masked and White-Coat Hypertension

Two patterns only visible with out-of-office monitoring deserve special attention. White-coat hypertension means clinic readings are elevated but home/ambulatory readings are normal — cardiovascular risk is intermediate, and most patients do not need drug therapy but should be reassessed yearly. Masked hypertension is the inverse: clinic readings look normal but out-of-office pressure is high, and risk is comparable to sustained hypertension. Both are recognized phenotypes in the ACC/AHA 2017 guideline (PMID 29133356) and are missed entirely if you rely on office readings alone.

Resistant Hypertension and When to Investigate Secondary Causes

Resistant hypertension is BP above goal despite three antihypertensive drugs at maximum tolerated doses (one of which should be a diuretic), or BP at goal but requiring four or more drugs. The 2018 AHA scientific statement (Carey RM et al., Hypertension, PMID 30354828) estimates true resistant hypertension affects roughly 10% of treated adults once white-coat effect, poor adherence and inadequate dosing are excluded.

Resistant or early-onset hypertension (before age 30), abrupt worsening, or hypertension with hypokalemia should trigger evaluation for secondary causes — primary aldosteronism, renal artery stenosis, obstructive sleep apnea, thyroid disease, pheochromocytoma, Cushing syndrome, or medication-related (NSAIDs, decongestants, oral contraceptives, glucocorticoids, stimulants). This work-up belongs with your physician — do not self-diagnose.

Special Populations

Pregnancy: BP above 140/90 mmHg after 20 weeks of gestation may indicate gestational hypertension or preeclampsia and requires same-week obstetric evaluation. Pregnant patients should not use most ACE inhibitors, ARBs or renin inhibitors. Always consult your obstetrician before continuing or changing antihypertensive therapy in pregnancy.

Older adults (≥65): the ACC/AHA 2017 guideline (PMID 29133356) endorses a systolic target <130 mmHg for non-institutionalized ambulatory adults, supported by SPRINT-Senior data (PMID 26551272), but clinicians should weigh fall risk, orthostatic hypotension, polypharmacy and life expectancy. Frail older adults often warrant a more individualized target.

People with diabetes: ADA and ACC/AHA generally agree on a target around 130/80 mmHg in most adults with diabetes, balancing cardiovascular and renal protection against hypotension risk. Your individual goal should be set with your physician.

Lifestyle Strategies to Lower Blood Pressure

The following evidence-based interventions are summarized in the ACC/AHA 2017 guideline (PMID 29133356); they work even without medication and amplify drug effects when therapy is needed.

Action Plan by BP Category

Use the CalcVita Blood Pressure Calculator to check your reading against AHA 2017 (adults) or AAP 2017 (children) thresholds and get your estimated population percentile. The tool does not replace clinical evaluation — share results with your physician.